Search research articles
Contact Us
Filters
Showing results (531-540 of 606) with videos related to
Page
of 61
Sort By:
Scientific Reports
|
July 27, 2017
Post-hypoxia Invasion of the fetal brain by multidrug resistant Staphylococcus
Miguel A Zarate, Michelle D Rodriguez, Eileen I Chang, et al.
Molecular Psychiatry
|
June 27, 2022
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
Gustavo C Medeiros, Todd D Gould, William L Prueitt, et al.
Translational Psychiatry
|
May 2, 2022
Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
Ruin Moaddel, Panos Zanos, Cristan A Farmer, et al.
Biological Psychiatry
|
December 21, 2010
The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder
Rodrigo Machado-Vieira, Natalia B Pivovarova, Ruslan I Stanika, et al.
Archives of General Psychiatry
|
January 12, 2002
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy
Mauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Clinical Genetics
|
August 9, 2017
Bone health and SATB2-associated syndrome
Y A Zarate, M Steinraths, A Matthews, et al.
American Journal of Medical Genetics. Part A
|
April 18, 2015
Further supporting evidence for the SATB2-associated syndrome found through whole exome sequencing
Yuri A Zarate, Hazel Perry, Tawfeg Ben-Omran, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 18, 2017
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder
Mark J Niciu, Nicolas D Iadarola, Dipavo Banerjee, et al.
The American Journal of Drug and Alcohol Abuse
|
August 22, 2025
Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression
Peter Manza, Annabelle M Belcher, Heather Fitzsimons, et al.
Psychopharmacology
|
January 6, 2016
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
Erica M Richards, Daniel C Mathews, David A Luckenbaugh, et al.
Page
of 61
Search research articles
Search
Showing results (531-540 of 606) with videos related to
Sort By:
Page
of 61
Scientific Reports
|
July 27, 2017
Post-hypoxia Invasion of the fetal brain by multidrug resistant Staphylococcus
Miguel A Zarate, Michelle D Rodriguez, Eileen I Chang, et al.
Molecular Psychiatry
|
June 27, 2022
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
Gustavo C Medeiros, Todd D Gould, William L Prueitt, et al.
Translational Psychiatry
|
May 2, 2022
Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
Ruin Moaddel, Panos Zanos, Cristan A Farmer, et al.
Biological Psychiatry
|
December 21, 2010
The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder
Rodrigo Machado-Vieira, Natalia B Pivovarova, Ruslan I Stanika, et al.
Archives of General Psychiatry
|
January 12, 2002
Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy
Mauricio Tohen, K N Roy Chengappa, Trisha Suppes, et al.
Clinical Genetics
|
August 9, 2017
Bone health and SATB2-associated syndrome
Y A Zarate, M Steinraths, A Matthews, et al.
American Journal of Medical Genetics. Part A
|
April 18, 2015
Further supporting evidence for the SATB2-associated syndrome found through whole exome sequencing
Yuri A Zarate, Hazel Perry, Tawfeg Ben-Omran, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 18, 2017
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder
Mark J Niciu, Nicolas D Iadarola, Dipavo Banerjee, et al.
The American Journal of Drug and Alcohol Abuse
|
August 22, 2025
Ketamine to enhance methadone treatment retention in patients with opioid use disorder and co-morbid depression
Peter Manza, Annabelle M Belcher, Heather Fitzsimons, et al.
Psychopharmacology
|
January 6, 2016
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
Erica M Richards, Daniel C Mathews, David A Luckenbaugh, et al.
Page
of 61